Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

Authors:
  • EOEugene Otlz
    Eugene Otlz

Abstract
SARS-CoV-2, the causative agent of COVID-19, is rapidly evolving to be more transmissible and to evade acquired immunity. To date, most investigations of SARS-CoV-2 variants have focused on RBD mutations.
Funding Information
  • HHS | National Institutes of Health (U54CA260582, R01AI150473)
  • HHS | National Institutes of Health (R01 HD095881, U54CA260582)
  • HHS | National Institutes of Health (U54CA260582)
  • HHS | National Institutes of Health (U54CA260582)
  • HHS | National Institutes of Health (U54CA260582, R01HL127442-01A1)

This publication has 25 references indexed in Scilit: